ALXO - Multiplikator P/S ALX Oncology

Tandha merek alxoncology.com (ALXO)

ALX Oncology Holdings (ALXO) competes for market share through safe inhibitors in combination therapy. Development relies on the success of clinical trials and external financing. The brand's high authority is confirmed by the development of efvapcept for combating tumors. The dynamics of the market cap-to-revenue ratio help assess the asset's value, with this metric currently equal to .

ALXO (ALX Oncology Holdings) riwayat Rasio rega marang pendapatan saka 04.07.2022 nganti 18.11.2026

ALX Oncology Holdings (ALXO) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
Analisis umum perusahaan:ALX Oncology Holdings, ALXO
Produk asil prodhuksi ALX Oncology Holdings Inc.

This metric is calculated as the ratio of market capitalization to annual revenue, reflecting the cost of each unit of sales. This multiple allows for an assessment of market expectations relative to the business's actual cash flows. For ALX Oncology Holdings (ALXO), during the expansion of Phase II/III clinical trials, the metric serves as an indicator of investor confidence in the future commercial success of its drugs. Analyzing the price-to-sales multiple on the GURU.Markets platform helps identify valuation deviations from the company's fundamental prospects.

Perusahaan pesaing

Kapitalisasi marang pendapatan ImmunityBio Corp IBRX|Immunocore Holdings - Kapitalisasi marang pendapatan|Multiplikator P/S Janux Corp JANX|RCUS - Rasio rega marang pendapatan|ZYME (zymeworks.com) - Rasio kapitalisasi marang pendapatan|Tango Therapeutics Corp (TNGX) - Rasio rega marang pendapatan|Rega marang dodolan Iovance (IOVA)|Kapitalisasi marang pendapatan IMTX|XNCR - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan CMPX (Compass Bio)|Kapitalisasi marang volume dodolan REPL|Multiplikator P/S LYEL (Lyell Immunopharma, Inc.)|Rasio kapitalisasi pasar marang pendapatan IPHA|Pyxis - Multiplikator P/S|Rega marang dodolan Compugen|IO Biotech, Inc. (IOBT) - Rasio rega marang pendapatan|Sutro Biopharma, Inc. - Rasio kapitalisasi pasar marang pendapatan|INKT (minktherapeutics.com) - Multiplikator P/S|Multiplikator P/S werewolftx.com|Rasio rega marang pendapatan immixbio.com (IMMX)|CUE - Rega marang dodolan|PDS Biotechnology Corporation - Kapitalisasi marang pendapatan|Sonnet BioTherapeutics (SONN) - Rega marang dodolan|MAIA - Rasio rega marang pendapatan|LIMN: Rasio rega marang pendapatan|LVTX: Multiplikator P/S|Rega marang dodolan NextCure, Inc. (NXTC)|LPTX (Leap Tx) - Multiplikator P/S|INTS (Intensity Therapeutics) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan Sensei Bio (SNSE)|TOVX (Theriva Biologics) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan gritstonebio.com GRTS|Rasio kapitalisasi pasar marang pendapatan KA|NEXI - Rasio rega marang pendapatan|Turnstone Biologics Corp. - Kapitalisasi marang volume dodolan|VCNX: Multiplikator P/S|Rasio kapitalisasi marang pendapatan HARP